A new study may have found a potentially easier, less disruptive and more effective way to treat the second leading cause of ...

Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit from intensified treatment. It is important to target intensified therapy ...

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...

Advanced digital pathology and biopsy analysis are used to identify patients who benefit from intensified prostate cancer treatment. The STAMPEDE trial demonstrated that adding Zytiga to standard ...

It’s among the most common cancers affecting older men. But a diagnosis today isn’t always what it seems. By David Dodge An estimated one in eight men will be diagnosed with prostate cancer in their ...

Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of ...

Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical ...